Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Interferon beta delays development of multiple sclerosis in high-risk subjects

Oct. 2, 2000

Endo meets with FDA to clarify requirements for MorphiDex approval

Oct. 2, 2000

Eisai receives patent for new compounds interacting with AMPA receptors

Sep. 29, 2000

New MMP inhibitors useful for multiple sclerosis, etc.

Sep. 29, 2000

University of Virginia researchers patent felbamate derivatives useful for neurological diseases

Sep. 29, 2000

Neurological compounds disclosed by Cephalon in patent literature

Sep. 29, 2000

Sagami receives patent for apoptosis inhibitor

Sep. 29, 2000

Fujisawa discontinues development of FK-888

Sep. 29, 2000

AstraZeneca synthesizes new selective opioid agonist analgesics

Sep. 29, 2000

Ampligen clears first stage of regulatory review in the E.U.

Sep. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...